We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Tocilizumab

News List

Remdesivir, tocilizumab being considered for ‘restricted use’ on severely ill COVID-19 patients expresspharma
June 12, 2020
Reportedly, some more drugs to be used in combination with hydroxychloroquine may be added to the protocol.
China approves use of Roche arthritis drug for some Covid-19 patients expresspharma
March 05, 2020
Tocilizumab, sold by the Swiss pharma giant under the trade name Actemra, can be prescribed to coronavirus patients who show serious lung damage.
Final NHS nod for Roche’s RoActemra pharmatimes
July 16, 2018
Roche/Chugai’s RoActemra should be routinely offered throughout the NHS to adults with giant cell arteritis (GCA) within the next three months, following a final green light from cost regulators.
Tocilizumab Beats Steroids for Controlling Blood Vessel Inflammation in Study drugs.com
July 27, 2017
The drug tocilizumab performs better than steroids in treating the most common form of blood vessel inflammation known as giant cell arteritis, a new study has shown.

Previous page 1 2 3 Next page